Year
2012
|
|
24.10.2012
|
Aarhus, Denmark, Semi-Final of HealthCare 2012 international Presentation of the Company
|
19.09.2012
|
Bilbao, BioSpain 2012 international Presentation of the Company
|
04.07.2012
|
SEF-Swiss
Start-Up Award, Zurich
|
20.03.2012
|
MedTech Investing Europe Conference,
Montreux
|
19.03.2012
|
3rd pat.pend.
preceded by the 1st CH684982 patent; 2nd CH701039 (A2); PCT-WO2012-xxxxxxxxx
pat.pend.
|
01.01.2012
|
Sale activities: third party sale, maximiseBE sales efforts.
|
Year
2011
|
|
21.11.2011
|
Study & FDA clearance
„clinical-trials.gov; NCT00407420 (Bristol Royal
Hospital,UK)/ (Dr. Per Sodersten, PhD, Karolinska
Institutet, Stockholm; FDA clearance http://www.mando.se/_uploads/_documents/News/Mandometer_Approved_By_FDA.pdf; New
York, N.Y., April 6, 2011; "proof of
concept"
|
29.09.2011
|
Business
competition Switzerland "Venture.ch", ETHZ/McKinsey
|
17.08.2011
|
Internet
presence
|
07.07.2011
|
Workshop
EUResearch about Clinical Trial
|
30.06.2011
|
Business
competition Austria "AdventurX (place < 10)"
|
30.06.2011
|
Business
competition Germany "Science4Life (place < 20)"
|
31.05.2011
|
MedTech
Investing Europe Conference, and EPFL, Lausanne, as well as in London, GB /
HongKong
|
Year
2010
|
|
15.11.2010
|
2nd pat.pend. preceded by the 1st
CH684982 patent; CH701039 (A2); PCT-WO2009-xxxxxxxxx
pat.pend.
|
01.11.2010
|
Venturelab 2010
planning and training stages
|
05.11.2010
|
Cessation of mass production due to a lack of financial
certainty
|
20.06.2010
|
Marketing and
PR concept
created by
Partner Company, May / June 2010
|
15.06.2010
|
As of day we have
10 fully
functional products available
which are
in test
use since
June 2010
|
01.03.2010
|
Foundation of Erib Ltd.
|
Year
2009
|
|
01.06.2009
|
Project design,
implementation and final stages of development
and prototypes have been completed
|
Year
2008
|
|
01.01.2008
|
Start and business disposition of "Erib
Corp"
|